Vitasora (ASX:VHL | OTCQB:RSHUF) is a leading U.S. Connected Care Management company, leveraging advanced technology, clinical expertise, and strategic partnerships to enhance patient outcomes, reduce healthcare costs, and drive value-based care. Vitasora’s bespoke Care Management model empowers healthcare organisations to extend care beyond their clinics, seamlessly integrating multi-device remote monitoring, virtual clinical support, and AI-powered decision-making. Vitasora’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and respiratory disease. Vitasora is strategically positioned to revolutionise chronic disease management globally and is focused on the U.S. market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.
Vitasora (ASX:VHL | OTCQB:RSHUF) is a leading U.S. Connected Care Management company, leveraging advanced technology, clinical expertise, and strategic partnerships to enhance patient outcomes, reduce healthcare costs, and drive value-based care. Vitasora’s bespoke Care Management model empowers healthcare organisations to extend care beyond their clinics, seamlessly integrating multi-device remote monitoring, virtual clinical support, and AI-powered decision-making. Vitasora’s mission is to improve health outcomes for patients with chronic diseases from cardiovascular, diabetes, obesity and respiratory disease. Vitasora is strategically positioned to revolutionise chronic disease management globally and is focused on the U.S. market, where RPM services are reimbursed by Current Procedural Terminology (CPT) Code reimbursement.